Allen Allison J, Ali Siraj M, Gowen Kyle, Elvin Julia A, Pejovic Tanja
Department of Obstetrics and Gynecology and the Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States.
Foundation Medicine, Inc., Cambridge, MA, United States.
Gynecol Oncol Rep. 2017 Mar 8;20:51-53. doi: 10.1016/j.gore.2017.03.002. eCollection 2017 May.
•Genomic alterations may improve diagnostic certainty and subsequent treatment of endometrial stromal sarcoma.•Novel JAZF1-BCORL1 mutation was identified.•Targeted therapeutics to down-stream targets may improve survival benefit in these patients.
•基因组改变可能提高子宫内膜间质肉瘤的诊断准确性及后续治疗效果。
•发现了新的JAZF1-BCORL1突变。
•针对下游靶点的靶向治疗可能改善这些患者的生存获益。